Semler Scientific/$SMLR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Semler Scientific

Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test. also invest in bitcoin and have adopted bitcoin as its treasury reserve asset. Company's healthcare technology solutions business is predominant operational focus, providing cash flows and enabling it to pursue bitcoin.

Ticker

$SMLR
Primary listing

Industry

Health Care Equipment and Supplies

Employees

79

ISIN

US81684M1045

SMLR Metrics

BasicAdvanced
$597M
-
-$3.78
1.34
-

What the Analysts think about SMLR

Analyst ratings (Buy, Hold, Sell) for Semler Scientific stock.

Bulls say / Bears say

Semler Scientific's strategic shift to a bitcoin treasury strategy has resulted in a 107% BTC yield since July 1, 2024, significantly enhancing shareholder value. (Semler Scientific Press Release)
The company reported a 99% increase in net income for the full year 2024, reaching $40.9 million, driven by gains from its bitcoin holdings. (Semler Scientific Press Release)
Semler Scientific's disciplined approach to expense management led to a 23% reduction in total operating expenses in 2024, contributing to improved profitability. (Semler Scientific Press Release)
The company's core healthcare business experienced a 17% decline in revenues in 2024, indicating potential challenges in its primary market. (Semler Scientific Press Release)
Semler Scientific's heavy reliance on two major customers, accounting for 71% of total revenue in 2024, poses a significant dependency risk. (Semler Scientific Press Release)
The company's aggressive bitcoin acquisition strategy introduces substantial volatility to earnings, as evidenced by the $28.8 million fair value gain in Q4 2024 alone. (Semler Scientific Press Release)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.

SMLR Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

SMLR Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SMLR

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs